Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 311.215
1.02 %
$ 167 B
Market Cap
41.22
P/E
AMGN - COST OF REVENUE
Cost of Revenue AMGN - Amgen Inc.
12.9 B
LAST VALUE
41.68%
2 YEAR CAGR
24.17%
5 YEAR CAGR
11.26%
10 YEAR CAGR